JP2001513526A - アントラニル酸類似体 - Google Patents
アントラニル酸類似体Info
- Publication number
- JP2001513526A JP2001513526A JP2000507205A JP2000507205A JP2001513526A JP 2001513526 A JP2001513526 A JP 2001513526A JP 2000507205 A JP2000507205 A JP 2000507205A JP 2000507205 A JP2000507205 A JP 2000507205A JP 2001513526 A JP2001513526 A JP 2001513526A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- acryloylamino
- benzoic acid
- hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90668397A | 1997-08-05 | 1997-08-05 | |
US08/906,683 | 1997-08-05 | ||
PCT/US1998/016099 WO1999007669A1 (en) | 1997-08-05 | 1998-08-03 | Anthranilic acid analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001513526A true JP2001513526A (ja) | 2001-09-04 |
Family
ID=25422806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000507205A Pending JP2001513526A (ja) | 1997-08-05 | 1998-08-03 | アントラニル酸類似体 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1003712A1 (pt) |
JP (1) | JP2001513526A (pt) |
CN (1) | CN1273579A (pt) |
AU (1) | AU8684598A (pt) |
BR (1) | BR9811845A (pt) |
CA (1) | CA2297412A1 (pt) |
WO (1) | WO1999007669A1 (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503385A (ja) * | 1999-06-25 | 2003-01-28 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インダニル置換ベンゼンカルボキサミド、その製造方法、薬剤としてのその使用およびそれを含有する医薬処方物 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19935219A1 (de) * | 1999-07-27 | 2001-02-01 | Boehringer Ingelheim Pharma | Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
DE10065042A1 (de) * | 2000-12-23 | 2002-06-27 | Boehringer Ingelheim Pharma | Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
US7429593B2 (en) | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
AU2003258491A1 (en) * | 2002-09-05 | 2004-03-29 | Neurosearch A/S | Amide derivatives and their use as chloride channel blockers |
WO2004047738A2 (en) * | 2002-11-22 | 2004-06-10 | Bristol-Myers Squibb Company | Arylcyclopropylcarboxylic amides as potassium channel openers |
GB0319124D0 (en) * | 2003-08-14 | 2003-09-17 | Smithkline Beecham Corp | Chemical compounds |
CN110357789B (zh) * | 2018-04-11 | 2022-09-30 | 华东理工大学 | 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5970654A (ja) * | 1982-10-15 | 1984-04-21 | Nippon Redarii Kk | アントラニル酸誘導体 |
JPS6097946A (ja) * | 1983-11-01 | 1985-05-31 | Ono Pharmaceut Co Ltd | カルボキサミド誘導体 |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
-
1998
- 1998-08-03 WO PCT/US1998/016099 patent/WO1999007669A1/en not_active Application Discontinuation
- 1998-08-03 BR BR9811845-5A patent/BR9811845A/pt not_active Application Discontinuation
- 1998-08-03 CA CA002297412A patent/CA2297412A1/en not_active Abandoned
- 1998-08-03 EP EP98938288A patent/EP1003712A1/en not_active Withdrawn
- 1998-08-03 AU AU86845/98A patent/AU8684598A/en not_active Abandoned
- 1998-08-03 JP JP2000507205A patent/JP2001513526A/ja active Pending
- 1998-08-03 CN CN98809866A patent/CN1273579A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503385A (ja) * | 1999-06-25 | 2003-01-28 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インダニル置換ベンゼンカルボキサミド、その製造方法、薬剤としてのその使用およびそれを含有する医薬処方物 |
Also Published As
Publication number | Publication date |
---|---|
CN1273579A (zh) | 2000-11-15 |
EP1003712A1 (en) | 2000-05-31 |
WO1999007669A1 (en) | 1999-02-18 |
AU8684598A (en) | 1999-03-01 |
CA2297412A1 (en) | 1999-02-18 |
BR9811845A (pt) | 2000-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6046239A (en) | Anthranilic acid analogs | |
US6127392A (en) | Anthranilic acid analogs | |
US6096770A (en) | Anthranilic acid analogs | |
KR100522011B1 (ko) | 설폰아미드 및 카르복사미드 유도체와, 이들을 유효 성분으로 함유하는 약제 | |
CA2606471C (en) | Benzisoxazole piperidine compounds and methods of use thereof | |
TWI409247B (zh) | 4-取代之苯氧基苯基乙酸衍生物 | |
JPH08508034A (ja) | フェノキシフェニル酢酸誘導体 | |
JP2004196702A (ja) | 新規なアミド誘導体又はその塩 | |
JPWO2008123207A1 (ja) | オルニチン誘導体 | |
JPH10310575A (ja) | 新規なキノリンスルフィド誘導体、その製造方法及び用途 | |
JP2001513526A (ja) | アントラニル酸類似体 | |
DE4327365A1 (de) | Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung | |
CA2419722A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
WO2003018515A2 (en) | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
AU2002331145A1 (en) | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
JP2007523873A (ja) | 新規化合物 | |
JP2001501179A (ja) | キヌレニン―3―ヒドロキシラーゼ抑制活性を有するn―置換―2―アミノ―4―フェニル―4―オキソ―ブタン酸 | |
JP2603639B2 (ja) | チアゾリジン―4―カルボン酸化合物、その製造方法、この化合物を含有する解熱消炎鎮痛剤および虚血・リパーフュージョン症候群治療薬 | |
JP2001513527A (ja) | アントラニル酸類似体 | |
TW201819361A (zh) | 新穎吲唑化合物 | |
MXPA00001261A (en) | Anthranilic acid analogs | |
PT88116B (pt) | Processo de preparacao de derivados de acido naftalenopropionico uteis como agentes anti-inflamatorios/antialergicos | |
AU727217B2 (en) | Heterocyclylmethylamino derivatives of cyclobutene-3,4- diones as potassium channel modulators | |
JP2008506680A (ja) | ピラゾリン誘導体、それを得るための方法および治療薬としてのその使用 | |
MXPA00001255A (en) | Anthranilic acid analogs |